Peng Yuan
- Oncology top 10%
- Molecular Biology
- Cancer Research top 5%
- Ophthalmology top 2%
- Radiology, Nuclear Medicine and Imaging top 5%
- Co-authors
- Michael R. RobinsonKarl G. CsakyRobert J. LutzHyuncheol KimGinger TanseyBinghe XuFei MaPeter M. Bungay
- Topics
- HER2/EGFR in Cancer Research (16 papers)Breast Cancer Treatment Studies (14 papers)Cancer Treatment and Pharmacology (8 papers)
- Cited by
- OphthalmologyCancer ResearchOncology
- Journals
- Nature CommunicationsSHILAP Revista de lepidopterologíaCancer Research
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Peng Yuan
64 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 105
- Oncology 409
- Molecular Biology 380
- Cancer Research 347
- Ophthalmology 298
- Radiology, Nuclear Medicine and Imaging 263
Countries citing papers authored by Peng Yuan
This map shows the geographic impact of Peng Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Yuan more than expected).
Fields of papers citing papers by Peng Yuan
This network shows the impact of papers produced by Peng Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Yuan. The network helps show where Peng Yuan may publish in the future.
Co-authorship network of co-authors of Peng Yuan
This figure shows the co-authorship network connecting the top 25 collaborators of Peng Yuan. A scholar is included among the top collaborators of Peng Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peng Yuan. Peng Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 5 | |
| 5 | 0 | |
| 6 | 6 | |
| 7 | 13 | |
| 8 | 1 | |
| 9 | 13 | |
| 10 | 7 | |
| 11 | 6 | |
| 12 | 14 | |
| 13 | 86 | |
| 14 | 27 | |
| 15 | 5 | |
| 16 | 21 | |
| 17 | 1 | |
| 18 | 51 | |
| 19 | Anterior Subtenon's Triamcinolone Acetonide (ASTTA) Injection for the Treatment of Diabetic Macular Edema: Animal and Clinical Findings | 2 |
| 20 | 37 |
About Peng Yuan
Peng Yuan is a scholar working on Cancer Research, Oncology and Ophthalmology, having authored 69 papers that have together received 1.2k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (16 papers), Breast Cancer Treatment Studies (14 papers) and Cancer Treatment and Pharmacology (8 papers). The work is most often cited by research in Ophthalmology (298 citations), Cancer Research (347 citations) and Oncology (409 citations). Peng Yuan has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Michael R. Robinson, Karl G. Csaky, Robert J. Lutz, Hyuncheol Kim, Ginger Tansey, Binghe Xu, Fei Ma, Peter M. Bungay, Martin J. Lizak and Pin Zhang. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.